These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 18279467)

  • 1. Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.
    Damaskos D; Kolios G
    Br J Clin Pharmacol; 2008 Apr; 65(4):453-67. PubMed ID: 18279467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
    Mitsuyama K
    Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut flora in health and disease.
    Guarner F; Malagelada JR
    Lancet; 2003 Feb; 361(9356):512-9. PubMed ID: 12583961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotics in chronic intestinal inflammation.
    Looijer-van Langen MA; Dieleman LA
    Inflamm Bowel Dis; 2009 Mar; 15(3):454-62. PubMed ID: 18831524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bacteria in experimental colitis.
    Guarner F; Malagelada JR
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):793-804. PubMed ID: 14507589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of intestinal flora in the treatment of inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Araki Y; Andoh A
    Curr Pharm Des; 2003; 9(4):333-46. PubMed ID: 12570821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for chronic intestinal disorders.
    Guslandi M
    Am J Gastroenterol; 2003 Mar; 98(3):520-1. PubMed ID: 12650780
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
    Sartor RB
    Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
    Andoh A; Fujiyama Y
    World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary VA; Boullata J
    J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and inflammatory bowel disease.
    Kwon J; Farrell R
    BioDrugs; 2003; 17(3):179-86. PubMed ID: 12749754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.